Expression of inhibitor of growth 4 by HSV1716 improves oncolytic potency and enhances efficacy. - Wikidata - awgldk - TriplyDB

Expression of inhibitor of growth 4 by HSV1716 improves oncolytic potency and enhances efficacy.

Expression of inhibitor of growth 4 by HSV1716 improves oncolytic potency and enhances efficacy.

http://www.wikidata.org/entity/Q34275711

about

Promising oncolytic agents for metastatic breast cancer treatment Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf.Inhibitor of growth-4 is a potential target for cancer therapy.Oncolytic virotherapy: the questions and the promise.INGs are potential drug targets for cancer.Immunotherapy for Breast Cancer: Current and Future Strategies.

P2860

Q26830620-55284FB6-8746-461A-9F61-F98F3B13A989 Q37031733-2740ADC0-327A-4D84-92EE-3287B15F1840 Q38657642-6E25C235-0ECD-4444-8828-97EDD43782E5 Q38709293-6C074DA1-7921-4705-A357-86E6C608C80E Q38924527-536A71EA-BE88-4FB3-9F2F-C05B64A7D888 Q38932782-BFF948DA-8EC8-48A2-9966-DA89C66ACCB7 Q52587066-491FDCE4-2E49-4ADB-8B99-051267A8360D

P2860

Expression of inhibitor of growth 4 by HSV1716 improves oncolytic potency and enhances efficacy.

http://www.wikidata.org/entity/Q34275711

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Expression of inhibitor of gro ...... potency and enhances efficacy.

@ast

Expression of inhibitor of gro ...... potency and enhances efficacy.

@en

Expression of inhibitor of gro ...... potency and enhances efficacy.

@nl

type

label

Expression of inhibitor of gro ...... potency and enhances efficacy.

@ast

Expression of inhibitor of gro ...... potency and enhances efficacy.

@en

Expression of inhibitor of gro ...... potency and enhances efficacy.

@nl

prefLabel

Expression of inhibitor of gro ...... potency and enhances efficacy.

@ast

Expression of inhibitor of gro ...... potency and enhances efficacy.

@en

Expression of inhibitor of gro ...... potency and enhances efficacy.

@nl

P1433

Q34275711-AB264D32-FC4C-4E86-B8D3-6E73769E7A1F

P1476

Q34275711-4B3C277A-F5E0-470A-9B91-24CC0B09FD16

P2093

Q34275711-96E47747-69A3-4D8B-B865-17F7D1202842

Q34275711-DFA8CA19-7677-453A-A6A5-DB15ADE59C7D

P2860

Q34275711-00FA74B7-E65C-4451-A6DF-C087DDD0EC8B

Q34275711-010B3579-4ACC-4C45-B3A4-30F5DB988E97

Q34275711-134D4902-28AE-4C8E-B282-315292A9CABE

Q34275711-16F8F289-8ACA-410B-9859-AEF2CF68155E

Q34275711-1E3463CF-9616-4570-A400-3AAD5E42B173

Q34275711-214EA252-5F6E-437F-921B-4FC97F22F0C7

Q34275711-239E5800-0491-4E32-A7B2-8F094C21E037

Q34275711-27E50647-F78B-412E-B403-3C1959B69AAE

Q34275711-2B3C5F65-6137-4DB4-B970-2FF3C1B0C4B1

Q34275711-305D7D8D-CAC5-4A3A-93E3-0A55B0B699BE

P2888

Q34275711-B063F5BF-61F7-48DF-9014-475430FE99C9

P304

Q34275711-7C93CCC6-A462-4C35-BEC3-A243C64005AF

P31

Q34275711-ABD079A2-5409-470E-AAC3-5EB83F74E922

P356

Q34275711-C0E117D2-7143-4DCF-AE92-E9FC12222C34

P433

Q34275711-687E0C02-5983-499D-B7C7-569BC2A03743

P478

Q34275711-242C7BE2-93B0-4ABE-98B6-D9C73AA22B9E

P577

Q34275711-DA2BFA36-3B3C-4B76-85E6-3492425E5957

P5875

Q34275711-580334A3-2758-4317-8259-5C97359834EF

P6179

Q34275711-5F267A52-C16B-45FD-AC2F-4500A44410C9

P698

Q34275711-FE61E6C9-A6D4-444D-B80B-97909330CA90

P356

P1433

Cancer Gene Therapy

P1476

Expression of inhibitor of gro ...... potency and enhances efficacy.

@en

P2093

J Conner

http://www.w3.org/2001/XMLSchema#string

L Braidwood

http://www.w3.org/2001/XMLSchema#string

P2860

ING4 induces G2/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in HepG2 cells

ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation

The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis

The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF).

ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation

A screen for genes that suppress loss of contact inhibition: identification of ING4 as a candidate tumor suppressor gene in human cancer

HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival.

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma.

The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study.

The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor.

P2888

P304

499-507

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CGT.2012.24

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224977675

http://www.w3.org/2001/XMLSchema#string

P6179

1004465048

http://www.w3.org/2001/XMLSchema#string

P698

22595793

http://www.w3.org/2001/XMLSchema#string